Natera Inc
NASDAQ:NTRA

Watchlist Manager
Natera Inc Logo
Natera Inc
NASDAQ:NTRA
Watchlist
Price: 161.88 USD 2.4% Market Closed
Market Cap: 21.4B USD
Have any thoughts about
Natera Inc?
Write Note

Wall Street
Price Targets

NTRA Price Targets Summary
Natera Inc

Wall Street analysts forecast NTRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NTRA is 183.83 USD with a low forecast of 158.57 USD and a high forecast of 219.45 USD.

Lowest
Price Target
158.57 USD
2% Downside
Average
Price Target
183.83 USD
14% Upside
Highest
Price Target
219.45 USD
36% Upside

NTRA Last Price Targets
Natera Inc

The latest public price target was made on Nov 13, 2024 by Catherine Ramsey Schulte from Robert W. Baird , who expects NTRA stock to drop by 1% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Catherine Ramsey Schulte
Robert W. Baird
160 USD
Downside 1%
1 month ago
Nov 13, 2024
Natera (NTRA) PT Raised to $160 at Baird
StreetInsider
Tycho Peterson
Jefferies
182 USD
Upside 12%
1 month ago
Nov 13, 2024
Natera (NTRA) PT Raised to $182 at Jefferies
StreetInsider
Kyle Mikson
Canaccord Genuity
150 USD
Downside 7%
1 month ago
Oct 29, 2024
Natera (NTRA) PT Raised to $150 at Canaccord Genuity
StreetInsider
Dave Westenberg
Piper Sandler
150 USD
Downside 7%
3 months ago
Sep 13, 2024
Piper Sandler Reiterates Overweight Rating on Natera (NTRA)
StreetInsider
Kyle Mikson
Canaccord Genuity
145 USD
Downside 10%
3 months ago
Aug 27, 2024
Natera price target raised to $145 from $130 at Canaccord
TheFly
Tejas Savant
Morgan Stanley
132 USD
Downside 18%
4 months ago
Aug 13, 2024
Natera price target raised to $132 from $125 at Morgan Stanley
TheFly
Catherine Ramsey Schulte
Robert W. Baird
120 USD
Downside 26%
4 months ago
Aug 9, 2024
Natera (NTRA) PT Raised to $120 at Baird
StreetInsider
Doug Schenkel
Wolfe Research
135 USD
Downside 17%
5 months ago
Jun 25, 2024
Wolfe Research Reiterates Outperform Rating on Natera (NTRA)
StreetInsider
Tycho Peterson
Jefferies
142 USD
Downside 12%
6 months ago
Jun 3, 2024
Natera assumed with a Buy at Jefferies
TheFly
David Westenberg
Piper Sandler
120 USD
Downside 26%
7 months ago
May 14, 2024
Natera price target raised to $120 from $110 at Piper Sandler
TheFly
Mark Massaro
BTIG
125 USD
Downside 23%
7 months ago
May 13, 2024
Natera price target raised to $125 from $100 at BTIG
TheFly
Catherine Ramsey Schulte
Robert W. Baird
117 USD
Downside 28%
7 months ago
May 10, 2024
Natera price target raised to $117 from $99 at Baird
TheFly
Eve Burstein
Bernstein
120 USD
Downside 26%
8 months ago
Apr 5, 2024
Bernstein SocGen Group Upgrades Natera (NTRA) to Outperform
StreetInsider
Show More Price Targets
Show Less Price Targets
Catherine Ramsey Schulte
Robert W. Baird
Price Target 160 USD
Upside/Downside 1%
View Source
Tycho Peterson
Jefferies
Price Target 182 USD
Upside/Downside 12%
View Source
Kyle Mikson
Canaccord Genuity
Price Target 150 USD
Upside/Downside 7%
View Source
Dave Westenberg
Piper Sandler
Price Target 150 USD
Upside/Downside 7%
View Source
Kyle Mikson
Canaccord Genuity
Price Target 145 USD
Upside/Downside 10%
View Source
Tejas Savant
Morgan Stanley
Price Target 132 USD
Upside/Downside 18%
View Source
Catherine Ramsey Schulte
Robert W. Baird
Price Target 120 USD
Upside/Downside 26%
View Source
Doug Schenkel
Wolfe Research
Price Target 135 USD
Upside/Downside 17%
View Source
Tycho Peterson
Jefferies
Price Target 142 USD
Upside/Downside 12%
View Source
David Westenberg
Piper Sandler
Price Target 120 USD
Upside/Downside 26%
View Source
Mark Massaro
BTIG
Price Target 125 USD
Upside/Downside 23%
View Source
Catherine Ramsey Schulte
Robert W. Baird
Price Target 117 USD
Upside/Downside 28%
View Source
Eve Burstein
Bernstein
Price Target 120 USD
Upside/Downside 26%
View Source
Show More Price Targets
Show Less Price Targets
Natera Inc Competitors:
Price Targets
ACLX
Arcellx Inc
57% Upside
AVTE
Aerovate Therapeutics Inc
6% Downside
PRLD
Prelude Therapeutics Inc
324% Upside
600201
Jinyu Bio-Technology Co Ltd
8% Upside
FLUO
Fluoguide AS
285% Upside
002252
Shanghai RAAS Blood Products Co Ltd
4% Downside
OXB
Oxford BioMedica PLC
30% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Natera Inc

For the last 8 years the compound annual growth rate for Natera Inc's revenue is 24%. The projected CAGR for the next 4 years is 22%.

24%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Natera Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Natera Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NTRA's stock price target?
Price Target
183.83 USD

According to Wall Street analysts, the average 1-year price target for NTRA is 183.83 USD with a low forecast of 158.57 USD and a high forecast of 219.45 USD.

What is Natera Inc's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Natera Inc's revenue is 24%. The projected CAGR for the next 4 years is 22%.

Back to Top